Laryngitis

Summary

Laryngitis (MONDO:0002647) is a disease and 5 clinical trials. A subtype of laryngeal disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 5

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	laryngitis
Mondo ID	MONDO:0002647
MeSH	D007827
DOID	DOID:3437
NCIT	C26811
SNOMED CT	45913009
UMLS	C0023067
MedGen	7273
Is cancer (heuristic)	no

Also known as: inflammation of larynx · laryngeal Inflammation · laryngeal inflammation · larynx inflammation

Disease family

This is a subtype of laryngeal disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › respiratory system disorder › upper respiratory tract disorder › laryngeal disorder › laryngitis

Related subtypes (19): spasmodic dystonia, laryngostenosis, laryngeal abductor paralysis, congenital laryngomalacia, larynx atresia, congenital laryngeal web, H syndrome, primary laryngeal lymphangioma, congenital laryngeal palsy, congenital subglottic stenosis, congenital laryngeal cyst, laryngocele, laryngeal diphtheria, laryngeal granuloma, laryngeal neoplasm, polyp of vocal cord, voice disorders, acquired laryngomalacia, idiopathic subglottic stenosis

Subtypes (4): laryngotracheitis, chronic laryngitis, acute laryngitis, laryngeal tuberculosis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 5.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	5

Top trials by phase / activity

NCT	Phase	Status	Title
NCT06023550	Not specified	RECRUITING	Complicated Infections in Otorhinolaryngology
NCT07359287	Not specified	RECRUITING	Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care
NCT00517114	Not specified	COMPLETED	Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients
NCT02048449	Not specified	COMPLETED	Inter-rater Reliability of the Reflux Finding Score Among Gastroenterologists
NCT04771221	Not specified	COMPLETED	Method of Early Diagnosis of Laryngopharyngeal Reflux